Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers
Clinical trial NCT05525780 · COMPLETED
Trial details
- NCT number
- NCT05525780
- Sponsor
- G2GBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2023-06-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.